303.31
+0.49
+(0.16%)
At close: January 29 at 4:00:02 PM EST
269.90
-33.41
(-11.02%)
Pre-Market: 9:13:56 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 24 | 20 |
| Avg. Estimate | 6.93 | 7.53 | 31.49 | 35.08 |
| Low Estimate | 6.06 | 7.24 | 31.01 | 34.47 |
| High Estimate | 7.68 | 7.93 | 32.03 | 35.55 |
| Year Ago EPS | 6.47 | 6.72 | 27.33 | 31.49 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 19 | 18 |
| Avg. Estimate | 59.75B | 62.29B | 252.42B | 265.79B |
| Low Estimate | 57.01B | 60.72B | 244.86B | 259.31B |
| High Estimate | 61.72B | 64.49B | 262.01B | 279.6B |
| Year Ago Sales | 57.25B | 60.47B | 247.1B | 252.42B |
| Sales Growth (year/est) | 4.37% | 3.01% | 2.15% | 5.30% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 6.22 | 6.42 | 7.25 | 7.82 |
| EPS Actual | 6.47 | 6.72 | 7.51 | 6.64 |
| Difference | 0.25 | 0.3 | 0.26 | -1.18 |
| Surprise % | 4.02% | 4.74% | 3.52% | -15.10% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 6.93 | 7.53 | 31.49 | 35.08 |
| 7 Days Ago | 6.94 | 7.53 | 31.5 | 35.08 |
| 30 Days Ago | 6.95 | 7.54 | 31.55 | 35.13 |
| 60 Days Ago | 6.95 | 7.54 | 31.58 | 35.16 |
| 90 Days Ago | 7.01 | 7.65 | 31.77 | 35.39 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 2 | 2 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CI | 7.16% | 11.98% | 15.21% | 11.41% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 11/5/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/5/2024 |
| Maintains | Deutsche Bank: Buy to Buy | 11/4/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 11/1/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 11/1/2024 |
Related Tickers
HUM Humana Inc.
294.23
-2.93%
ELV Elevance Health, Inc.
400.30
-1.26%
CNC Centene Corporation
63.91
-1.25%
UNH UnitedHealth Group Incorporated
538.10
-0.81%
MOH Molina Healthcare, Inc.
304.28
-1.02%
CVS CVS Health Corporation
56.90
-0.75%
OSCR Oscar Health, Inc.
16.68
+2.46%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
CLOV Clover Health Investments, Corp.
4.4500
-3.05%
NEUE NeueHealth, Inc.
7.34
-0.14%